Zhang John J Y, Ang Jensen, Saffari Seyed Ehsan, Tor Phern-Chern, Lo Yew Long, Wan Kai Rui
Department of Neurosurgery, National Neuroscience Institute, Singapore; Department of Neurosurgery, National Neuroscience Institute, Singapore General Hospital, Singapore.
Department of Neurosurgery, National Neuroscience Institute, Singapore; Department of Neurosurgery, National Neuroscience Institute, Singapore General Hospital, Singapore.
Neuromodulation. 2025 Jan;28(1):16-42. doi: 10.1016/j.neurom.2024.07.010. Epub 2024 Sep 24.
Repetitive transcranial magnetic stimulation (rTMS) has shown promising results in enhancing motor recovery after stroke, but nuances regarding its use, such as the impact of the type and site of stimulation, are not yet established. We aimed to perform a systematic review and meta-analysis of randomized controlled trials (RCTs) with low risk of bias to investigate the effect of rTMS on motor recovery after both ischemic and hemorrhagic stroke.
Three databases were searched systematically for all RCTs reporting comparisons between rTMS (including theta-burst stimulation) and either no stimulation or sham stimulation up to August 19, 2022. The primary outcome measure was the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). Secondary outcome measures comprised the Action Research Arm Test, Box and Block Test, Modified Ashworth Scale for the wrist, and modified Rankin Scale (mRS).
A total of 37 articles reporting 48 unique comparisons were included. Pooled mean FMA-UE scores were significantly higher in the experimental group than the control group after intervention (MD = 5.4 [MD = 10.7 after correction of potential publication bias], p < 0.001) and at the last follow-up (MD = 5.2, p = 0.031). On subgroup analysis, the improvements in FMA-UE scores, both after intervention and at the last follow-up, were significant in the acute/subacute stage of stroke (within six months) and for patients with more severe baseline motor impairment. Both contralesional and ipsilesional stimulation yielded significant improvements in FMA-UE at the first assessment after rTMS but not at the last follow-up, while the improvements from bilateral rTMS only achieved statistical significance at the last follow-up. Among the secondary outcome measures, only mRS was significantly improved in the rTMS group after intervention (MD = -0.5, p = 0.013) and at the last follow-up (MD = -0.9, p = 0.001).
Current literature supports the use of rTMS for motor recovery after stroke, especially when done within six months and for patients with more severe stroke at baseline. Future studies with larger sample sizes may be helpful in clarifying the potential of rTMS in poststroke rehabilitation.
重复经颅磁刺激(rTMS)在促进中风后运动功能恢复方面已显示出有前景的结果,但关于其使用的细微差别,如刺激类型和部位的影响,尚未明确。我们旨在对偏倚风险较低的随机对照试验(RCT)进行系统评价和荟萃分析,以研究rTMS对缺血性和出血性中风后运动恢复的影响。
系统检索了三个数据库,以查找截至2022年8月19日所有报告rTMS(包括theta爆发刺激)与无刺激或假刺激比较的RCT。主要结局指标是上肢Fugl-Meyer评估量表(FMA-UE)。次要结局指标包括动作研究臂试验、箱块测试、腕部改良Ashworth量表和改良Rankin量表(mRS)。
共纳入37篇文章,报告了48项独特的比较。干预后(MD = 5.4 [校正潜在发表偏倚后MD = 10.7],p < 0.001)和末次随访时(MD = 5.2,p = 0.031),实验组的合并平均FMA-UE评分显著高于对照组。亚组分析显示,在中风的急性/亚急性阶段(六个月内)以及基线运动障碍较严重的患者中,干预后和末次随访时FMA-UE评分均有显著改善。对侧和同侧刺激在rTMS后的首次评估时FMA-UE均有显著改善,但在末次随访时无改善,而双侧rTMS的改善仅在末次随访时达到统计学意义。在次要结局指标中,仅mRS在干预后(MD = -0.5,p = 0.013)和末次随访时(MD = -0.9,p = 0.001)在rTMS组中有显著改善。
当前文献支持使用rTMS促进中风后运动恢复,尤其是在六个月内进行且针对基线中风较严重的患者。未来更大样本量的研究可能有助于阐明rTMS在中风后康复中的潜力。